Elizabeth R. Vanderwall

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

Fred D. Mast, Peter C. Fridy, Natalia E. Ketaren et al. · eLife · 2021 · 70 citations · Full text

Engineering, Immunology, Viral Pathogenesis +18

IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

Malika Hale, Jason Netland, Yu Chen et al. · The Journal of Experimental Medicine · 2022 · 47 citations · Full text

Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells

Naresh Doni Jayavelu, Matthew C. Altman, Basilin Benson et al. · Journal of Allergy and Clinical Immunology · 2023 · 32 citations · Full text

Asthma, Inflammation, Functional Alteration +13

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication

Elizabeth R. Vanderwall, Kaitlyn A. Barrow, Lucille M. Rich et al. · Scientific Reports · 2022 · 26 citations · Full text

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells

Oghenemega Okoloko, Elizabeth R. Vanderwall, Lucille M. Rich et al. · Frontiers in Pharmacology · 2021 · 12 citations · Full text